Brain natriuretic peptide levels in the obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
Association between obstructive sleep apnea and elevated levels of B-type natriuretic peptide in a community based sample of women Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Plasma n-terminal pro-brain natriuretic peptide (NT pro-BNP) level in respiratory diseases Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003
Natriuretic peptide in sleep apnea – relation with hypoxia Source: Eur Respir J 2007; 30: Suppl. 51, 334s Year: 2007
Diagnostic value of N-terminal pro-brain natriuretic peptide in patients with COPD with chronic hypoxemic respiratory failure. Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020
Vasopressin, atrial natriuretic peptide and adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008
The use of plasma n-terminal pro B-type natriuretic peptide (proBNP) concentrations in differential diagnosis of comorbidity pulmonary patients Source: Annual Congress 2011 - Acute respiratory failure Year: 2011
NT-pro BNP is a marker for cardiovascular dysfunction due to obstructive sleep apnea syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
The prognostic value of repeated measurements of N-terminal pro-B-type natriuretic peptide in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010
Correlation of levels of N-terminal pro-B-type natriuretic peptide with localization of thrombus in acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
The role of pro-brain natriuretic peptide and C-reactive protein as prognostic markers in stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Determination of B-type natriuretic peptide in patients with chronic heart failure and Cheyne-Stokes respiration Source: Eur Respir J 2004; 24: Suppl. 48, 563s Year: 2004
Pro-atrial natriuretic peptide increases during a failed spontaneous breathing trial Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009
Diagnostic value of N-terminal pro-brain natriuretic peptide levels in pleural effusions of cardiac origin Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH Source: ERJ Open Res, 6 (4) 00356-2020; 10.1183/23120541.00356-2020 Year: 2020
Serum levels of high sensitivity cardiac troponin and B-type natriuretic peptide in patients with COPD-OSA overlap syndrome Source: Sleep and Breathing Conference 2021 Year: 2021
Comparison of brain natriuretic peptide to n-terminal pro brain natriuretic peptide in idiopathic interstitial pneumonia Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Source: Eur Respir J 2010; 35: 95-104 Year: 2010
Brain natriuretic peptide (BNP) levels during acute exacerbations of COPD – a novel biomarker Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008